Influence of the use of hormonal contraceptives on cancer risk of BRCA1/2-pV carriers or carriers with pV in other breast and/or ovarian cancer risk genes after diagnosis of breast cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.